TAIDOC TECHNOLOGY CORP (4736) - Cash Flow Conversion Efficiency
Based on the latest financial reports, TAIDOC TECHNOLOGY CORP (4736) has a cash flow conversion efficiency ratio of 0.024x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$238.93 Million ≈ $7.53 Million USD) by net assets (NT$9.96 Billion ≈ $313.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TAIDOC TECHNOLOGY CORP (4736) defensive interval to measure how many days the company can operate on defensive assets alone.
TAIDOC TECHNOLOGY CORP - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how TAIDOC TECHNOLOGY CORP's cash flow conversion efficiency has evolved over time, based on yearly financial data.
TAIDOC TECHNOLOGY CORP Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TAIDOC TECHNOLOGY CORP ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chongqing YuXin Pingrui Electronic Co. Ltd.
SHE:301107
|
0.011x |
|
Raisio Oyj Vaihto-osake
HE:RAIVV
|
0.035x |
|
Shaanxi Jinye Science Technology and Education Group Co Ltd
SHE:000812
|
0.148x |
|
Ample Electronic Technology Co Ltd
TWO:4760
|
-0.014x |
|
Zhongxing Shenyang Commercial Building Group Co Ltd
SHE:000715
|
0.029x |
|
Sprout Social Inc
NASDAQ:SPT
|
0.117x |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
-0.040x |
|
Enseval Putra Megatrading Tbk
JK:EPMT
|
0.035x |
Annual Cash Flow Conversion Efficiency for TAIDOC TECHNOLOGY CORP (2009–2025)
The table below shows the annual cash flow conversion efficiency of TAIDOC TECHNOLOGY CORP from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of TAIDOC TECHNOLOGY CORP.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | NT$10.12 Billion ≈ $318.98 Million |
NT$853.39 Million ≈ $26.89 Million |
0.084x | +542.57% |
| 2024-09-30 | NT$9.52 Billion ≈ $300.01 Million |
NT$-181.37 Million ≈ $-5.71 Million |
-0.019x | -115.05% |
| 2023-09-30 | NT$9.26 Billion ≈ $291.71 Million |
NT$1.17 Billion ≈ $36.93 Million |
0.127x | -60.58% |
| 2022-09-30 | NT$9.99 Billion ≈ $314.89 Million |
NT$3.21 Billion ≈ $101.12 Million |
0.321x | +27.70% |
| 2021-09-30 | NT$7.63 Billion ≈ $240.53 Million |
NT$1.92 Billion ≈ $60.48 Million |
0.251x | -1.04% |
| 2020-09-30 | NT$6.62 Billion ≈ $208.59 Million |
NT$1.68 Billion ≈ $53.00 Million |
0.254x | +5.41% |
| 2019-09-30 | NT$4.51 Billion ≈ $142.12 Million |
NT$1.09 Billion ≈ $34.26 Million |
0.241x | +23.91% |
| 2018-09-30 | NT$4.02 Billion ≈ $126.75 Million |
NT$782.66 Million ≈ $24.66 Million |
0.195x | +18.66% |
| 2017-09-30 | NT$3.18 Billion ≈ $100.15 Million |
NT$521.21 Million ≈ $16.42 Million |
0.164x | -20.71% |
| 2016-09-30 | NT$3.08 Billion ≈ $96.90 Million |
NT$636.01 Million ≈ $20.04 Million |
0.207x | +18.63% |
| 2015-09-30 | NT$2.91 Billion ≈ $91.80 Million |
NT$507.88 Million ≈ $16.00 Million |
0.174x | -26.06% |
| 2014-09-30 | NT$2.49 Billion ≈ $78.42 Million |
NT$586.76 Million ≈ $18.49 Million |
0.236x | +32.93% |
| 2013-09-30 | NT$2.11 Billion ≈ $66.57 Million |
NT$374.74 Million ≈ $11.81 Million |
0.177x | +40.30% |
| 2012-09-30 | NT$1.96 Billion ≈ $61.74 Million |
NT$247.71 Million ≈ $7.80 Million |
0.126x | -28.47% |
| 2011-09-30 | NT$2.05 Billion ≈ $64.73 Million |
NT$363.06 Million ≈ $11.44 Million |
0.177x | +460.23% |
| 2010-09-30 | NT$2.27 Billion ≈ $71.41 Million |
NT$71.50 Million ≈ $2.25 Million |
0.032x | -88.51% |
| 2009-09-30 | NT$1.70 Billion ≈ $53.59 Million |
NT$466.80 Million ≈ $14.71 Million |
0.274x | -- |
About TAIDOC TECHNOLOGY CORP
TaiDoc Technology Corporation manufactures and markets medical devices in Taiwan and internationally. The company offers In vitro diagnostics products, including multiple parameter monitoring systems, point of care testing devices, and lancet and lancing devices; vet health care products comprise blood glucose and calcium meters, and blood ketone meters; and medical devices, such as nebulizers, t… Read more